FU-MK-1 expression in human gallbladder carcinoma: An antigenic prediction marker for a better postsurgical prognosis

American Journal of Clinical Pathology

Volumn 132, Issue 1, 2009, Pages 111-117

  Ikeda, Takeaki ^a   Nakayama, Yoshifuku ^a   Hamada, Yoshihiro ^a   Takeshita, Morishige ^a   Iwasaki, Hiroshi ^a   Maeshiro, Kensei ^a   Yamashita, Yuichi ^a   Kuroki, Masahide ^a   Ikeda, Seiyo ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

FU MK 1; Gallbladder carcinoma; MK 1; Predictive factor

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY FU MK 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHOLECYSTECTOMY; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR BIOPSY;

ADENOCARCINOMA; ADENOCARCINOMA, PAPILLARY; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CHOLECYSTECTOMY; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; JAPAN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 67650484922     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCP5HPHG6NGBWZO     Document Type: Article

References (18)

1. Gore RM, Shelhamer RP. Biliary tract neoplasms: diagnosis and staging. Cancer Imaging. 2007;7(Spec No A):S15-S23.
2. Kayahara M, Nagakawa T. Recent trends of gallbladder cancer in Japan: an analysis of 4,770 patients. Cancer. 2007;110:572-580.
3. Nagahashi M, Ajioka Y, Lang I, et al. Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol. 2008;14:70-75.
4. Onoyama H, Yamamoto M, Tseng A, et al. Extended cholecystectomy for carcinoma of the gallbladder. World J Surg. 1995;19:758-763.
5. Onoyama H, Ajiki T, Takada M, et al. Does radical resection improve the survival in patients with carcinoma of the gallbladder who are 75 years old and older? World J Surg. 2002;26:1315-1318.
6. Watanabe R, Johzaki H, Iwasaki H, et al. A new tumor-associated antigen defined by a monoclonal antibody directed to gastric adenocarcinoma. Cancer. 1993;71:2439-2447.
7. Arakawa F, Yamamoto T, Kanda H, et al. cDNA sequence analysis of monoclonal antibody FU-MK-1 specific for a transmembrane carcinoma-associated antigen, and construction of a mouse/human chimeric antibody. Hybridoma. 1999;18:131-138.
8. Winter MJ, Nagtegaal ID, van Krieken JHJM, et al. The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. Am J Pathol. 2003;163:2139-2148.
9. Albores-Saavedra J, Scoazec JC, Wittekind C, et al. Histological classification of the gallbladder and extrahepatic bile ducts. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000:206-213.
10. Hamada Y, Nakayama Y, Mizoguchi M, et al. MK-1 expression in carcinoma of the ampulla of Vater as a predictor of improved prognosis after surgical resection. Cancer Lett. 2006;7:1-6.
11. Chijiiwa K, Yamaguchi K, Tanaka M. Clinicopathologic differences between long-term and short-term postoperative survivors with advanced gallbladder carcinoma. World J Surg. 1997;21:98-102.
12. Ouchi K, Suzuki M, Tominaga T, et al. Survival after surgery for cancer of the gallbladder. Br J Surg. 1994;81:1655-1657.
13. Ishihara S, Miyakawa S, Takada T, et al. Status of surgical treatment of biliary tract cancer. Dig Surg. 2007;24:131-136.
14. Litvinov SV, van Driel W, van Rhijn CM, et al. Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol. 1996;148:865-875.
15. Piyathilake CJ, Frost AR, Weiss H, et al. The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung. Hum Pathol. 2000;31:482-487.
16. Gastl G, Spizzo G, Obrist P, et al. Ep-CAM overexpression in breast cancer as a predictor of survival [letter]. Lancet. 2000;356:1981-1982.
17. Varga M, Obrist P, Schneeberger S, et al. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival. Clin Cancer Res. 2004;10:3131-3136.
18. Prince S, Zeidman A, Dekel Y, et al. Expression of epithelial cell adhesion molecule in gallbladder carcinoma and its correlation with clinicopathologic variables. Am J Clin Pathol. 2008;129:424-429.